Get inside of Wall Road with StreetInsider High quality. Claim your 1-week totally free demo below.
– New government brings around 20 decades of knowledge serving as CFO for publicly-traded biopharmaceutical corporations as Edgewise advances clinical muscular dystrophy program –
BOULDER, Colo.–(Organization WIRE)–
Edgewise Therapeutics, a clinical-stage biopharmaceutical company producing little molecule therapies for musculoskeletal illnesses, nowadays announced the appointment of R. Michael Carruthers to the newly created posture of Chief Economic Officer (CFO). Mr. Carruthers brings around two decades of encounter serving as CFO for publicly-traded biopharmaceutical corporations, with comprehensive working experience across corporate finance and strategic